Angion Biomedica Corp.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | 0 | 0% |
| P/S |
|
10.13 | 33.75 | -69.99% |
|
|
| P/BV |
|
0.53 | 4.82 | -89% |
|
|
| P/FCF |
|
-0.4179 | 61 | -100.69% |
|
|
| Ev/Ebitda |
|
1.19 | -22.17 | -105.37% |
|
|
| Ev/S |
|
-35.83 | 22.56 | -258.85% |
|
|
| Ev/FCF |
|
0.4179 | 68.75 | -99.39% |
|
|
| E/P |
|
-1.24 | 0.0178 | -7076.61% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3.15 | 4.98 | -163.25% | -882.66 | -99.64% |
| ROE |
|
-54.47 | 9.61 | -666.71% |
|
|
| ROA |
|
-20.89 | 0.3443 | -6168.1% |
|
|
| ROIC |
|
-37.87 | 7.63 | -596.05% |
|
|
| ROS |
|
-4456.36 | -25.17 | 17604.96% |
|
|
| ROCE |
|
0 | 15.35 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0146 | -3.68 | -99.6% | -0.2519 | -94.22% |
| Nеt Debt/Ebitda |
|
0 | -3.44 | -100% |
|
|
| Debt/Ratio |
|
0.0063 | 0.1985 | -96.84% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.0102 | 10.32 | -100.1% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
134.46 | 43.56 | 208.64% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
2720 | -56.89 | -4881.16% | ||
| Growth impulse Ebitda in 5 years |
|
-82.72 | -54.68 | 51.28% | ||
| Growth impulse Net Income in 5 years |
|
-57.32 | -58.33 | -1.73% | ||
| Growth impulse FCF in 5 years |
|
379.88 | -49.48 | -867.74% | ||
| Growth impulse EPS in 5 years |
|
-55.39 | -32.41 | 70.9% |
IP Score
4.04/10
